Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06336928

A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis

Status
Recruiting
Phase
Study type
Observational
Enrollment
490 (estimated)
Sponsor
University of Southern California · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study evaluates whether a special type of blood analysis, called liquid biopsy (LBx), correlates with mammography results and/or diagnosis of breast cancer.

Detailed description

PRIMARY OBJECTIVES: I. Determine the sensitivity of LBx for the presence of breast cancer in patient cohorts II. Determine the specificity of LBx for the presence of breast cancer in all patient cohorts. OUTLINE: This is an observational study. Patients undergo blood sample collection and have their medical records reviewed on study.

Conditions

Interventions

TypeNameDescription
OTHERNon-Interventional StudyNon-interventional study

Timeline

Start date
2024-06-07
Primary completion
2029-06-07
Completion
2030-06-07
First posted
2024-03-29
Last updated
2026-03-12

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06336928. Inclusion in this directory is not an endorsement.